Target Healthcare REIT’s (THRL) “Buy” Rating Reiterated at Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reiterated by equities researchers at Jefferies Financial Group in a research report issued to clients and investors on Wednesday, Digital Look reports. They currently have a GBX 124 price objective on the stock. Jefferies Financial Group‘s price objective suggests a potential upside of 3.16% from the stock’s previous close.

Target Healthcare REIT Stock Performance

Target Healthcare REIT stock opened at GBX 120.20 on Wednesday. Target Healthcare REIT has a fifty-two week low of GBX 92 and a fifty-two week high of GBX 120.60. The stock has a market cap of £745.52 million, a P/E ratio of 9.02, a PEG ratio of 1.48 and a beta of 0.71. The firm’s fifty day moving average price is GBX 113.17 and its 200-day moving average price is GBX 108.36.

Target Healthcare REIT (LON:THRL) last posted its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. Sell-side analysts predict that Target Healthcare REIT will post 6.22 earnings per share for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.